Merck KGaA (OTCMKTS:MKKGY) Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPS

Posted by Tyrone Williams on May 15th, 2026

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.45 by $0.14, Zacks reports. The company had revenue of $6.03 billion for the quarter, compared to the consensus estimate of $5.93 billion. Merck KGaA had a return on equity of 8.93% and a net margin of 12.07%.

Merck KGaA Trading Down 2.8%

Shares of OTCMKTS:MKKGY traded down $0.79 during midday trading on Friday, reaching $27.29. 57,047 shares of the company’s stock were exchanged, compared to its average volume of 118,793. The firm’s 50 day simple moving average is $25.96 and its two-hundred day simple moving average is $27.55. The stock has a market cap of $17.64 billion, a price-to-earnings ratio of 12.13, a P/E/G ratio of 2.58 and a beta of 0.97. Merck KGaA has a fifty-two week low of $23.73 and a fifty-two week high of $31.00. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.46 and a quick ratio of 0.96.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on MKKGY shares. Deutsche Bank Aktiengesellschaft cut shares of Merck KGaA from a “buy” rating to a “hold” rating in a report on Tuesday, February 3rd. Sanford C. Bernstein upgraded Merck KGaA to a “hold” rating in a research note on Thursday, March 19th. Four analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Merck KGaA currently has an average rating of “Hold”.

View Our Latest Analysis on MKKGY

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.